Association of lipoprotein(a) with intrinsic and on-clopidogrel platelet reactivity Alexander KilleThomas NührenbergWillibald Hochholzer OriginalPaper Open access 02 July 2021 Pages: 1 - 9
Patients with autoimmune chronic inflammatory diseases present increased biomarkers of thromboinflammation and endothelial dysfunction in the absence of flares and cardiovascular comorbidities Panagiota AnyfantiEleni GavriilakiEugenia Gkaliagkousi OriginalPaper 05 July 2021 Pages: 10 - 16
The clot thickens—enhanced integration of stroke and thrombosis training Stephanie CarlinWilliam GeertsHouman Khosravani BriefCommunication 07 July 2021 Pages: 17 - 19
Performance of the academic research consortium high-bleeding risk criteria in patients undergoing PCI for acute myocardial infarction Johny NicolasFrans BeerkensRoxana Mehran OriginalPaper 04 August 2021 Pages: 20 - 29
Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event Kiara C. S. ZapponiFernanda A. OrsiJoyce Maria Annichino-Bizzacchi OriginalPaper Open access 27 August 2021 Pages: 30 - 42
Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation Shuai YuanMaria BruzeliusSusanna C. Larsson OriginalPaper Open access 27 May 2021 Pages: 43 - 50
Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review Ramy SedhomMichael MegalyAman Amanullah ReviewPaper 16 June 2021 Pages: 51 - 57
Pragmatic study of a thromboprophylaxis algorithm in critically ill patients with SARS-COV-2 infection Maurizio FattoruttoYves BouckaertArnaud Bruyneel OriginalPaper 26 June 2021 Pages: 58 - 66
Risk of recurrent venous thromboembolism and bleeding in patients with interstitial lung disease: a cohort study Raphael Le MaoThomas RoparsFrancis Couturaud OriginalPaper 07 July 2021 Pages: 67 - 73
Oral anticoagulation for patients with atrial fibrillation in the ED: RE-LY AF registry analysis Pablo A. MendozaWilliam F. McIntyrethe RE-LY AF Registry Investigators OriginalPaper 02 August 2021 Pages: 74 - 82
ICODE: the international COVID-19 thrombosis biomarkers colloquium—novel soluble biomarkers: circulating cell-free nucleic acids and other molecules Krystin KrauelDaniel Duerschmied OriginalPaper Open access 12 May 2021 Pages: 83 - 87
Association between previous anticoagulant use and mortality among hospitalized patients with COVID-19 Oktay GülcüEmrah Aksakalİbrahim Halil Tanboğa OriginalPaper 02 June 2021 Pages: 88 - 95
Impact of pre-admission antithrombotic therapy on disease severity and mortality in patients hospitalized for COVID-19 Mariana CorrochanoRené Acosta-IsaacJoan Carles Souto OriginalPaper 17 June 2021 Pages: 96 - 102
Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study) Luis GarcÃa de Guadiana-RomualdoDaniel Morell-GarcÃaAmparo Galán Ortega OriginalPaper 16 July 2021 Pages: 103 - 112
U shape association of hemoglobin level with in-hospital mortality for COVID-19 patients Toshiki KunoMatsuo SoNatalia N. Egorova BriefCommunication 02 July 2021 Pages: 113 - 117
Evaluation of coagulation status using clot waveform analysis in general ward patients with COVID-19 Junko IchikawaRyouta OkazakiMakiko Komori BriefCommunication 14 July 2021 Pages: 118 - 122
MicroRNA-29b reduces myocardial ischemia–reperfusion injury in rats via down-regulating PTEN and activating the Akt/eNOS signaling pathway Kunsheng LiPengyu ZhouDongjin Wang OriginalPaper 09 August 2021 Pages: 123 - 135
Overexpression of miR-1298 attenuates myocardial ischemia–reperfusion injury by targeting PP2A Chun OuyangLei HuangZhen Han OriginalPaper 05 August 2021 Pages: 136 - 148
Rotational thromboelastometry and conventional coagulation tests in patients undergoing major cardiac or aortic surgery: a retrospective single-center cohort study Cornelius KeylAlbina BashotaDietmar Trenk OriginalPaper Open access 07 July 2021 Pages: 149 - 157
Impact of a pharmacist driven anticoagulation reversal program at a large academic medical center Gabrielle L. ProcopioRuchi Patel JainKeri Bicking OriginalPaper 07 June 2021 Pages: 158 - 166
Andexanet alfa and four-factor prothrombin complex concentrate for reversal of apixaban and rivaroxaban in patients diagnosed with intracranial hemorrhage Mark L. VestalKimberly HodulikIan J. Welsby OriginalPaper 08 June 2021 Pages: 167 - 175
Practice patterns surrounding referral to a specialty venous thromboembolism (VTE) clinic: a retrospective review Sarah LandryShannon IpTammy J. Bungard BriefCommunication 19 June 2021 Pages: 176 - 181
Risk factors of thrombotic recurrence and major bleeding in patients with intermediate-risk for recurrence of venous thromboembolism Yugo YamashitaHidewo Amanothe COMMAND VTE Registry Investigators OriginalPaper 06 July 2021 Pages: 182 - 190
Relations between left atrial appendage contrast retention and thromboembolic risk in patients with atrial fibrillation Xu LuTao ChenJun Guo OriginalPaper 15 June 2021 Pages: 191 - 201
Incidence and patient characteristics of venous thromboembolism during neoadjuvant chemotherapy for ovarian cancer Sagar K. ChokshiJohn P. GaughanLauren Krill OriginalPaper 29 June 2021 Pages: 202 - 207
Inhibitory effects of amniotic fluid on the activated protein C anticoagulation system in maternal plasma Divyanu JainTomoaki OdaNaoaki Tamura BriefCommunication 06 July 2021 Pages: 208 - 212
The first report of a JAK2 V617F-positive myeloproliferative neoplasm with initial manifestation as a rare pampiniform venous plexus thrombosis and review of the literature Jeremy JacobsDeva SharmaCindy Vnencak-Jones BriefCommunication 09 July 2021 Pages: 213 - 217
Adverse consequences of immediate thrombolysis-related complications: a multi-centre registry-based cohort study of acute stroke Thang S. HanGiosue GulliPankaj Sharma OriginalPaper Open access 13 July 2021 Pages: 218 - 227
Transient endothelial injury and release of lupus anticoagulant in COVID-19 Antonin TrimailleBenjamin MarchandotOlivier Morel Letter to the Editor 28 May 2021 Pages: 228 - 230
Increased incidence of massive hemorrhage at uncommon sites after initiation of systemic anticoagulation in critically ill patients with coronavirus disease 2019 (COVID-19) infection Salwa A. KoubaissiMichella Abi Zeid DaouAhmad Husari Letter to the Editor 28 May 2021 Pages: 231 - 234
Apixaban and rivaroxaban anti-Xa level utilization for guidance of administration of andexanet alfa: a case series Celia MortonAnnette ListaKevin R. Donahue Letter to the Editor 08 July 2021 Pages: 235 - 239